{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,18]],"date-time":"2023-09-18T04:50:20Z","timestamp":1695012620209},"reference-count":10,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1097\/mjt.0b013e3182459c16","type":"journal-article","created":{"date-parts":[[2013,5,10]],"date-time":"2013-05-10T10:43:09Z","timestamp":1368182589000},"page":"e53-e55","source":"Crossref","is-referenced-by-count":3,"title":["Direct Renin Inhibitor Induced Renal Failure"],"prefix":"10.1097","volume":"21","author":[{"given":"Ajay","family":"Vallakati","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Preeti A.","family":"Chandra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerald","family":"Hollander","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacob","family":"Shani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-19-20210202","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.jash.2007.04.004","article-title":". Antihypertensive efficacy, safety, and tolerability of the oral direct renin inhibitor aliskiren in patients with hypertension: a pooled analysis.","volume":"1","author":"Weir","year":"2007","journal-title":"J Am Soc Hypertens"},{"key":"R2-19-20210202","doi-asserted-by":"crossref","first-page":"326","DOI":"10.5414\/CNP71326","article-title":". Aliskiren-associated acute renal failure with hyperkalemia.","volume":"71","author":"Venzin","year":"2009","journal-title":"Clin Nephrol"},{"key":"R3-19-20210202","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1517\/14740338.4.4.689","article-title":"Drug-induced nephropathy: an update.","volume":"4","author":"Perazella","year":"2005","journal-title":"Expert Opin Drug Saf"},{"key":"R4-19-20210202","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1161\/01.CIR.0000156466.02908.ED","article-title":". Aliskiren, a novel orally effective renin inhibitor, provides dose-dependent antihypertensive efficacy and placebo-like tolerability in hypertensive patients.","volume":"111","author":"Gradman","year":"2005","journal-title":"Circulation"},{"key":"R5-19-20210202","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1161\/01.HYP.0000253780.36691.4f","article-title":". Aliskiren reduces blood pressure and suppresses renin activity with thiazide diuretic, an angiotensin-converting enzyme inhibitor, or an angiotensin receptor blocker.","volume":"49","author":"OBrien","year":"2007","journal-title":"Hypertension"},{"key":"R6-19-20210202","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1056\/NEJMoa0708379","article-title":". Aliskiren combined with losartan in type 2 diabetes and nephropathy.","volume":"358","author":"Parving","year":"2008","journal-title":"New Engl J Med"},{"key":"R7-19-20210202","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.amjmed.2007.11.016","article-title":"Oral direct renin inhibition: premise, promise, and potential limitations of a new antihypertensive drug.","volume":"121","author":"Shafiq","year":"2008","journal-title":"Am J Med"},{"key":"R8-19-20210202","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1161\/01.HYP.0000101688.17370.87","article-title":". Blood pressure lowering in essential hypertension with an oral renin inhibitor, aliskiren.","volume":"42","author":"Stanton","year":"2003","journal-title":"Hypertension"},{"key":"R9-19-20210202","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1161\/CIRCHEARTFAILURE.107.740704","article-title":". Aliskiren observation of heart failure treatment (ALOFT) Investigators.","volume":"1","author":"McMurray","year":"2008","journal-title":"Circ Heart Fail"},{"key":"R10-19-20210202","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1093\/oxfordjournals.ndt.a092076","article-title":". Acute renal failure after the use of angiotensin-converting enzyme inhibitors in patients without renal artery stenosis.","volume":"7","author":"Bridoux","year":"1992","journal-title":"Nephrol Dial Transplant"}],"container-title":["American Journal of Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MJT.0b013e3182459c16","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T03:36:52Z","timestamp":1620963412000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00045391-201403000-00019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":10,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/mjt.0b013e3182459c16","relation":{},"ISSN":["1075-2765"],"issn-type":[{"value":"1075-2765","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3]]}}}